302,395 Shares in Encompass Health Corporation $EHC Bought by Trillium Asset Management LLC

Trillium Asset Management LLC purchased a new stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 302,395 shares of the company's stock, valued at approximately $30,566,000. Encompass Health makes up about 0.9% of Trillium Asset Management LLC's investment portfolio, making the stock its 26th biggest position. Trillium Asset Management LLC owned about 0.30% of Encompass Health as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of EHC. WPG Advisers LLC raised its position in shares of Encompass Health by 73.3% during the 4th quarter. WPG Advisers LLC now owns 324 shares of the company's stock valued at $34,000 after buying an additional 137 shares in the last quarter. Persistent Asset Partners Ltd purchased a new stake in Encompass Health during the second quarter valued at approximately $36,000. Assetmark Inc. raised its position in Encompass Health by 89.6% during the first quarter. Assetmark Inc. now owns 455 shares of the company's stock valued at $44,000 after purchasing an additional 215 shares during the period. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Encompass Health by 36,200.0% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company's stock worth $46,000 after purchasing an additional 362 shares during the period. Finally, Aster Capital Management DIFC Ltd bought a new position in shares of Encompass Health during the 4th quarter valued at approximately $55,000. Institutional investors own 97.25% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have commented on EHC. TD Cowen lifted their price objective on shares of Encompass Health from $125.00 to $140.00 and gave the stock a "buy" rating in a research note on Monday, August 10th. Barclays lifted their price target on shares of Encompass Health from $140.00 to $144.00 and gave the stock an "overweight" rating in a research note on Thursday, August 6th. Weiss Ratings raised shares of Encompass Health from a "hold (c+)" rating to a "buy (b-)" rating in a research report on Wednesday, August 12th. Wall Street Zen upgraded Encompass Health from a "hold" rating to a "buy" rating in a research report on Sunday, August 16th. Finally, Truist Financial upped their target price on Encompass Health from $140.00 to $150.00 and gave the company a "buy" rating in a research note on Friday, August 7th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has issued a Hold rating to the company's stock. According to MarketBeat.com, Encompass Health currently has an average rating of "Buy" and an average price target of $148.71.

Encompass Health Stock Performance

Shares of Encompass Health stock opened at $120.89 on Friday. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.76. The stock's fifty day moving average price is $110.63 and its 200-day moving average price is $106.29. The firm has a market cap of $11.93 billion, a P/E ratio of 19.69, a P/E/G ratio of 2.47 and a beta of 0.72. Encompass Health Corporation has a 12 month low of $92.77 and a 12 month high of $127.99.

Encompass Health (NYSE:EHC - Get Free Report) last issued its earnings results on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.48 by $0.07. Encompass Health had a net margin of 10.01% and a return on equity of 18.08%. The company had revenue of $1.60 billion for the quarter, compared to analysts' expectations of $1.57 billion. During the same period in the prior year, the business earned $1.40 EPS. The firm's quarterly revenue was up 9.6% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. On average, equities research analysts expect that Encompass Health Corporation will post 6.08 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be issued a dividend of $0.21 per share. The ex-dividend date of this dividend is Thursday, October 1st. This is a positive change from Encompass Health's previous quarterly dividend of $0.19. This represents a $0.84 annualized dividend and a yield of 0.7%. Encompass Health's dividend payout ratio is 12.38%.

Insider Buying and Selling

In other Encompass Health news, CEO Mark J. Tarr sold 173,148 shares of the company's stock in a transaction on Monday, August 10th. The stock was sold at an average price of $125.47, for a total transaction of $21,724,879.56. Following the completion of the sale, the chief executive officer owned 267,814 shares in the company, valued at $33,602,622.58. This represents a 39.27% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP John Patrick Darby sold 8,906 shares of the stock in a transaction on Monday, August 10th. The shares were sold at an average price of $125.95, for a total value of $1,121,710.70. Following the sale, the executive vice president directly owned 75,041 shares in the company, valued at $9,451,413.95. This trade represents a 10.61% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 1.80% of the company's stock.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source